SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Meghmani Finechem - Quaterly Results

05 Aug 2023 Evaluate
A decrease in the sales to Rs. 4548.92 millions was observed for the quarter ended June 2023. The sales stood at Rs. 5328.50 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 316.77 millions from Rs. 1077.92 millions, a decline of -70.61% on QoQ basis.A decline of 967.17 millions was observed in the OP in the quarter ended June 2023 from 1894.93 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 4548.92 5328.50 -14.63 4548.92 5328.50 -14.63 21884.00 15509.41 41.10
Other Income 15.24 20.30 -24.93 15.24 20.30 -24.93 79.84 41.11 94.21
PBIDT 967.17 1894.93 -48.96 967.17 1894.93 -48.96 6969.81 5135.97 35.71
Interest 183.35 111.22 64.85 183.35 111.22 64.85 655.02 442.70 47.96
PBDT 783.82 1783.71 -56.06 783.82 1783.71 -56.06 6314.79 4693.27 34.55
Depreciation 308.02 220.39 39.76 308.02 220.39 39.76 1089.53 859.06 26.83
PBT 475.80 1563.32 -69.56 475.80 1563.32 -69.56 5225.26 3834.21 36.28
TAX 159.03 485.40 -67.24 159.03 485.40 -67.24 1691.68 1306.36 29.50
Deferred Tax 70.53 204.93 -65.58 70.53 204.93 -65.58 748.61 609.63 22.80
PAT 316.77 1077.92 -70.61 316.77 1077.92 -70.61 3533.58 2527.85 39.79
Equity 415.50 415.50 0.00 415.50 415.50 0.00 415.50 415.50 0.00
PBIDTM(%) 21.26 35.56 -40.21 21.26 35.56 -40.21 31.85 33.12 -3.82

Epigral Share Price

1328.80 125.55 (10.43%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3651.95
Tata Chemicals 804.85
SRF 2551.40
Pidilite Inds. 1364.45
Deepak Nitrite 1751.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×